Hepion Pharmaceuticals up 222% since four insiders bought
- Insider
- Vincent S. LoPriore
- Role
- Executive Chairman
- Company
- Hepion Pharmaceuticals (HEPA)
- Transaction
- Buy
- Shares
- 10M
- Amount
- $500K
- Trade date
- Aug 3, 2026
- Filed
- Aug 12, 2026, 9 days after the trade
- Source
- SEC Form 4 ↗
Executive Chairman Vincent S. LoPriore bought 10M Hepion Pharmaceuticals shares at $0.05 on Aug 3, for a total of $500K. Three other insiders also disclosed purchases that day.
The stock traded at $0.19 on Oct 29, 222% above the first close after the purchase. The purchase was larger than each of the 16 earlier insider purchases at Hepion in our records since 2020.
The Form 4 reached the SEC on Aug 12, 9 days after the trade. No sales by LoPriore have been reported since, 87 days after the purchase.
HEPA +28.6% on the day, close Oct 30
Since purchase+222.0%$0.06 → $0.19 at 13:29 ET
Since filing+171.4%$0.07 on Aug 13 → $0.19
Purchase$500K10M shares on Aug 3, 2026
Days since purchase87No sales by this filer since
Price since the purchase
Daily close · USD+200%
+100%
+50%
0%
Aug 4 · first close $0.06Oct 29 · $0.19
PurchaseFirst close above +200%